跳至主要内容
临床试验/EUCTR2005-001670-27-GB
EUCTR2005-001670-27-GB进行中(未招募)不适用

Reversibility of cerebrovascular endothelial dysfunction in diabetes: the role of allopurinol.

Greater Glasgow NHS Health Board / University of Glasgow co-sponsorship0 个研究点目标入组 24 人开始时间: 2005年10月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Type II diabetes of less than 5 years' duration treated with diet, metformin, thiazolidinediones or a combination of above
  • Age > 40 years
  • Normal full Bruce protocol exercise tolerance test
  • Favourable temporal bony window
  • Stable glycaemic control (HbA1c < 9.0%)
  • Stable cholesterol (total cholesterol < 7.5
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • >70% extra-cranial internal carotid artery stenosis
  • Known coronary arterial disease
  • Significant co-morbidity
  • Contra-indication to or indication for administration of allopurinol
  • Concurrent azathioprine or 6-mercaptopurine therapy
  • Insulin or sulphonylurea therapy
  • Serum creatinine concentration greater than 250 micromoles per litre

研究者

发起方
Greater Glasgow NHS Health Board / University of Glasgow co-sponsorship

相似试验